Build in-person connections

The US Pharma and Biotech Summit will be returning in 2024 to New York. Industry leaders will discuss regional and global trends in areas such as drug discovery, clinical development and market access. 

Industry leaders will gather to address the challenges and opportunities of today and tomorrow, from building partnerships and developing new treatments to investing in technology and preparing for the next global health emergency.

What's on?

Experience hard-hitting keynote interviews, panel discussions and unmissable networking in-person and online. Delegates will be able to collaborate and share ideas on the challenges and opportunities facing the industry in areas such as drug development, market access and workforce management. 

We will be asking key questions including: 

• What could a new economic cycle mean for the pharma industry?
• How is AI being plugged into drug discovery models?
• How are pharma workforces changing with the integration of young talent?  
• How could the outcome of the presidential election impact life sciences?

Who will you meet?

• CEOs and board members from top life sciences companies
  
  
• Vice Presidents, Heads of and Senior Directors from a wide range of pharma and biotech job functions
  
  
• C-suite executives from contract research organizations and other industry suppliers
  
  
• Senior journalists from the FT and other global press outlets

Speaking Opportunities

Ciaran Larkin
ciaran.larkin@ft.com

Sponsorship

Holly Watson-Steward
holly.watson-steward@ft.com  

Delegate Services 

Hauwra Sharif
hauwra.sharif@ft.com 

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice